Senior Director, Early Differentiation & Pipeline Strategy (EDAPS), Oncology

Bristol Myers Squibb•Princeton, NJ

2d•$229,380 - $277,956•Hybrid

About The Position

The Early Differentiation and Pipeline Strategy (EDAPS) team sits within the Global Medical Oncology organization under Global Medical Affairs and partners with Research and the Early Clinical Development teams within R&D. The team is responsible for the global Medical strategy for all hematology and oncology (HO) assets from candidate selection to clinical proof-of-concept (PoC) stage of the drug development cycle. The EDAPS Global Medical Lead is responsible for the development and execution of BMS’ global medical strategy for a subset of assets within the HO early development portfolio and is accountable to the early asset Development teams. The Lead will support the development of clinically differentiated compounds via interpretation of evolving pre-clinical & clinical data and engaging with thought leaders (TLs) early and often during the pre-POC phase of asset lifecycles.

Requirements

Advanced degree - MD, PharmD, or PhD
8-10 years clinical, medical, or other pharma industry experience
A breadth of relevant industry experience (Medical Affairs, Translational Medicine, and/or Clinical Development)
Therapeutic experience in malignant hematology and/or oncology; working knowledge of basic and clinical science and early drug development
Proven ability to interact with thought leaders and key customers in the early clinical space
Demonstrated ability to manage multiple assets, priorities, and decision timelines in a complex, matrixed environment and lead without direct authority
Excellent communication skills, including the ability to synthesize complex scientific and clinical information and construct a compelling value narrative to influence and align diverse stakeholders

Responsibilities

Medical accountability for a set of early HO assets; matrix management responsibilities across the internal network (R&D, Medical, and Commercial)
As a core member of early asset Global Program Teams (GPTs), be a critical thought partner to the Global Program Leads, Clinical Development leads, Translational Medicine leads, and HO Medical/Commercial teams, to deliver against objectives and program milestones
Ensure the development of a clearly differentiated early TPP for each asset and contribute to the early Clinical Development Plan at DC readiness by bringing in early scientific, clinical, and patient input (differentiation; unlocking new indications and combinations)
Own the early Integrated Evidence Plan (IEP-lite) for select assets that drive innovative data generation to accelerate and de-risk clinical development in collaboration with the respective GPT and external scientific partnerships
Own the medical communications strategy for each asset and work with the publications team to develop the scientific narratives (e.g., describing MoA) and develop and execute a robust publication strategy
Partner with external Thought Leaders and Patient Advocacy groups on an ongoing basis to gain medical advice on compound strategies with a goal to inform asset decision making and portfolio tradeoffs
Lead the planning and execution of advisory boards
Exercise enterprise mindset with a strong ability to work in a highly matrixed environment
Be a science-driven Medical Affairs professional with high business acumen

Benefits

wellbeing support
retirement and financial protection benefits
insurance offerings (medical, dental, vision, life and disability)
Flexible Time Off (FTO)
11 paid company holidays
160 hours of paid vacation annually
3 optional holidays
paid sick leave
up to two paid volunteer days per year
summer hours flexibility
leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs
annual Global Shutdown between Christmas Day and New Year's Day